BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 35606650)

  • 1. Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.
    Maronese CA; Pimentel MA; Li MM; Genovese G; Ortega-Loayza AG; Marzano AV
    Am J Clin Dermatol; 2022 Sep; 23(5):615-634. PubMed ID: 35606650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation.
    Marzano AV; Borghi A; Meroni PL; Cugno M
    Br J Dermatol; 2016 Nov; 175(5):882-891. PubMed ID: 27106250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative and Peristomal Pyoderma Gangrenosum: Subtypes of Pyoderma Gangrenosum.
    Kipers T; Tolkachjov SN
    Dermatol Clin; 2024 Apr; 42(2):171-181. PubMed ID: 38423679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum-like lesions in the setting of IgA cutaneous vasculitis: Favourable response to adalimumab.
    Sugino H; Kawahara H; Yamamoto K; Okada E; Sawada Y
    Skin Health Dis; 2024 Apr; 4(2):e347. PubMed ID: 38577052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Review of Neutrophilic Diseases.
    Marzano AV; Borghi A; Wallach D; Cugno M
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):114-130. PubMed ID: 28688013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucocutaneous pyoderma gangrenosum: a case report and literature review.
    Đorđević Betetto L; Točkova O; Bergant Suhodolčan A
    Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(Suppl):S10-S13. PubMed ID: 35339135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Pyoderma Gangrenosum.
    Tan MG; Tolkachjov SN
    Dermatol Clin; 2024 Apr; 42(2):183-192. PubMed ID: 38423680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple cavitary pulmonary nodules in association with pyoderma gangrenosum: case report.
    Bittencourt Mde J; Soares LF; Lobato LS; Mançano AD; Leandro HS; Fonseca DM
    An Bras Dermatol; 2012; 87(2):301-4. PubMed ID: 22570038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].
    Trémezaygues L; Schmaltz R; Vogt T; Reichrath J
    Hautarzt; 2010 Apr; 61(4):345-53; quiz 354-5. PubMed ID: 20361320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilic dermatoses and inflammatory bowel diseases.
    Marzano AV; Menicanti C; Crosti C; Trevisan V
    G Ital Dermatol Venereol; 2013 Apr; 148(2):185-96. PubMed ID: 23588144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review.
    Yamanaka K
    J Dermatol; 2024 Feb; 51(2):172-179. PubMed ID: 38009911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyoderma gangrenosum in a patient with essential thrombocythemia.
    King KW; Murray A
    J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
    Vinkel C; Thomsen SF
    Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of pyoderma gangrenosum (PG): an updated review.
    Braswell SF; Kostopoulos TC; Ortega-Loayza AG
    J Am Acad Dermatol; 2015 Oct; 73(4):691-8. PubMed ID: 26253362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease.
    Flora A; Kozera E; Frew JW
    Exp Dermatol; 2022 Apr; 31(4):498-515. PubMed ID: 35114021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Neutrophilic Dermatoses.
    Moreno-Artero E; Torrelo A
    Dermatol Clin; 2024 Apr; 42(2):267-283. PubMed ID: 38423686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophilic dermatoses: Pyoderma gangrenosum and other bowel- and arthritis-associated neutrophilic dermatoses.
    Ashchyan HJ; Nelson CA; Stephen S; James WD; Micheletti RG; Rosenbach M
    J Am Acad Dermatol; 2018 Dec; 79(6):1009-1022. PubMed ID: 29653213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma Gangrenosum: Diagnostic Criteria, Subtypes, Systemic Associations, and Workup.
    Zaino ML; Schadt CR; Callen JP; Owen LG
    Dermatol Clin; 2024 Apr; 42(2):157-170. PubMed ID: 38423678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.